Skip to main content
Erschienen in: NeuroMolecular Medicine 4/2020

19.08.2020 | Original Paper

Quercetin Ameliorates CFA-Induced Chronic Inflammatory Hyperalgesia via Modulation of ROS-Mediated ERK1/2 Signaling and Inhibition of Spinal Glial Activation In Vivo

verfasst von: Sanjay Kumar, Manjula Vinayak

Erschienen in: NeuroMolecular Medicine | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Impact of reactive oxygen species (ROS) in development of hyperalgesia has recently motivated scientists to focus on ROS as novel target of anti-hyperalgesic interventions. Studies have indicated the usefulness of ROS scavengers and exogenous antioxidants as anti-nociceptive agents in animal models of neuropathic and inflammatory hyperalgesia. In present study, we suggest the anti-hyperalgesic potential of the dietary antioxidant quercetin on chronic inflammatory hyperalgesia induced by Complete Freund’s Adjuvant (CFA). Three doses of quercetin (25, 50 and 75 mg/kg body weight) for consecutive 7 days were used for the study. Thermal hyperalgesia was assessed by paw withdrawal latency (PWL) test and inflammation was checked in terms of changes in paw edema. The insight of molecular signaling during chronic hyperalgesia was analyzed by TNF-α–TNFR1–ERK1/2 pathway in relation to change in ROS level in DRG and spinal cord. CFA-induced hyperalgesia was confirmed by decreased PWL and increased c-Fos activity in dorsal horn of spinal cord, determined by immunohistochemical analysis. It was characterized with elevated level of ROS and TNF-α estimated by ELISA. The activation of ERK1/2 and NF-κB in DRG and spinal cord and over-expression of TNFR1 in DRG were analyzed by Western blotting. Up-regulation of Iba1 and GFAP indicates glial activation in spinal cord. Expression of GFAP and its co-localization with NF-κB were examined by immunofluorescence. All the molecular modulators of hyperalgesia were brought towards normal after quercetin treatment showing its anti-hyperalgesic activity, indicating that repeated quercetin treatment is able to alleviate chronic inflammatory hyperalgesia by attenuating TNF-α-TNFR1–ERK1/2 signaling pathway via modulation of ROS and by suppression of central sensitization via inhibition of spinal glial activation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Ahmad, A. H., & Ismail, Z. (2002). c-fos and its Consequences in Pain. Malaysian Journal of Medical Science, 9(1), 3–8. Ahmad, A. H., & Ismail, Z. (2002). c-fos and its Consequences in Pain. Malaysian Journal of Medical Science, 9(1), 3–8.
Zurück zum Zitat Das, L., & Vinayak, M. (2014). Long term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancer. PLoS ONE, 9(6), e99583.PubMedPubMedCentral Das, L., & Vinayak, M. (2014). Long term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancer. PLoS ONE, 9(6), e99583.PubMedPubMedCentral
Zurück zum Zitat Harris, J. A. (1998). Using c-fos as a neural marker of pain. Brain Research Bulletin, 45(1), 1–8.PubMed Harris, J. A. (1998). Using c-fos as a neural marker of pain. Brain Research Bulletin, 45(1), 1–8.PubMed
Zurück zum Zitat Kuner, R. (2010). Central mechanisms of pathological pain. Nature Medicine, 16, 1258–1266.PubMed Kuner, R. (2010). Central mechanisms of pathological pain. Nature Medicine, 16, 1258–1266.PubMed
Zurück zum Zitat Luo, J. G., Zhao, X. L., Xu, W. C., Zhao, X. J., Wang, J. N., Lin, X. W., et al. (2014). Activation of spinal NF-kappaB/p65 contributes to peripheral inflammation and hyperalgesia in rat adjuvantinduced arthritis. Arthritis & Rheumatology, 66, 896–906. https://doi.org/10.1002/art.38328.CrossRef Luo, J. G., Zhao, X. L., Xu, W. C., Zhao, X. J., Wang, J. N., Lin, X. W., et al. (2014). Activation of spinal NF-kappaB/p65 contributes to peripheral inflammation and hyperalgesia in rat adjuvantinduced arthritis. Arthritis & Rheumatology, 66, 896–906. https://​doi.​org/​10.​1002/​art.​38328.CrossRef
Zurück zum Zitat Narenjkar, J., Roghani, M., Alambeygi, H., & Sedaghati, F. (2011). The effect of the flavonoid quercetin on pain sensation in diabetic rats. Basic and Clinical Neuroscience, 2(3), 51–57. Narenjkar, J., Roghani, M., Alambeygi, H., & Sedaghati, F. (2011). The effect of the flavonoid quercetin on pain sensation in diabetic rats. Basic and Clinical Neuroscience, 2(3), 51–57.
Zurück zum Zitat Skopelja-Gardner, S., Saha, M., Alvarado-Vazquez, P. A., Liponis, B. S., Martinez, E., & Romero-Sandoval, E. A. (2017). Mitogen-activated protein kinase phosphatase-3 (MKP-3) in the surgical wound is necessary for the resolution of postoperative pain in mice. Journal of Pain Research, 10(763–774), 2017. https://doi.org/10.2147/JPR.S129826.eCollection.CrossRef Skopelja-Gardner, S., Saha, M., Alvarado-Vazquez, P. A., Liponis, B. S., Martinez, E., & Romero-Sandoval, E. A. (2017). Mitogen-activated protein kinase phosphatase-3 (MKP-3) in the surgical wound is necessary for the resolution of postoperative pain in mice. Journal of Pain Research, 10(763–774), 2017. https://​doi.​org/​10.​2147/​JPR.​S129826.​eCollection.CrossRef
Zurück zum Zitat Wang, C., Song, S., Zhang, Y., Ge, Y., Fang, X., Huang, T., et al. (2015). Inhibition of the Rho/Rho kinase pathway prevents lipopolysaccharide-induced hyperalgesia and the release of TNF-α and IL-1β in the mouse spinal cord. Scientific Reports, 5, 145–153. https://doi.org/10.1038/srep14553.CrossRef Wang, C., Song, S., Zhang, Y., Ge, Y., Fang, X., Huang, T., et al. (2015). Inhibition of the Rho/Rho kinase pathway prevents lipopolysaccharide-induced hyperalgesia and the release of TNF-α and IL-1β in the mouse spinal cord. Scientific Reports, 5, 145–153. https://​doi.​org/​10.​1038/​srep14553.CrossRef
Metadaten
Titel
Quercetin Ameliorates CFA-Induced Chronic Inflammatory Hyperalgesia via Modulation of ROS-Mediated ERK1/2 Signaling and Inhibition of Spinal Glial Activation In Vivo
verfasst von
Sanjay Kumar
Manjula Vinayak
Publikationsdatum
19.08.2020
Verlag
Springer US
Erschienen in
NeuroMolecular Medicine / Ausgabe 4/2020
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI
https://doi.org/10.1007/s12017-020-08609-z

Weitere Artikel der Ausgabe 4/2020

NeuroMolecular Medicine 4/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.